Back HBV Epidemiology

HBV Epidemiology & Mortality

More U.S. Immigrants May Have Hepatitis B than Previously Estimated

The number of foreign-born individuals with chronic hepatitis B virus (HBV) infection in the U.S. may be considerably higher than earlier estimates suggest, according to a study described in the November 22, 2011, advance online edition of Hepatology.alt

Read more:

Causes of Death Among People with Hepatitis B and C

Deaths due to most liver-related causes dropped among people with hepatitis B, and people with hepatitis C were less likely to die of drug-related causes, but mortality due to hepatocellular carcinoma remained stable, according to a large Australian study. Coinfection with HIV increased mortality significantly. alt

Read more:

San Francisco Launches Hepatitis B Campaign to Raise Awareness in Asian Community

Coinciding with National Hepatitis B Awareness Month, San Francisco Hep B Free launched a new ad campaign this week to raise awareness about hepatitis B within the city's Asian communities, and to encourage testing and vaccination. The campaign includes print and television ads in several languages (including Chinese, Korean, and Vietnamese) as well as information directed at English-speaking medical providers. Asian Americans have a high rate of hepatitis B -- an estimated 1 in 10 infected -- and San Francisco, with its large Asian population, has the nation's highest rate of liver cancer.

Read more:

Hepatitis B Vaccination Dramatically Lowers Prevalence among U.S. Children

Children and adolescents in the U.S. today have a very low likelihood of hepatitis B virus (HBV) infection thanks to widespread vaccination, according to an epidemiological study described in the March 1, 2011, Annals of Internal Medicine. Many adults remain vulnerable, however, underlining the importance of vaccination for at-risk groups. alt

Read more:

CDC Reports Dramatic Declines in New Cases of Hepatitis A, B, and C

Hepatitis B and C have become growing public health concerns in recent years, as people infected decades ago begin to develop complications of chronic liver disease, including cirrhosis and hepatocellular carcinoma. But the rates of new hepatitis A, B, and C infections have decreased dramatically over the past 10-15 years, according to a new surveillance study by the Centers for Disease Control and Prevention (CDC), published in the March 16, 2007 issue of Morbidity and Mortality Weekly Report.

Read more: